Fine needle aspiration biopsy cytopathology (FNAC) of lymph nodes is a very common, inexpensive, and rapid diagnostic procedure and can lead to the accurate and timely diagnosis of one of the wide range of pathological processes that involve lymph nodes. These diagnoses include specific reactive processes, specific infections such as tuberculosis, metastatic carcinomas and melanomas, and some lymphomas. The FNAC effectively triages the lymph node material, but the initial diagnosis often requires ancillary testing as a second diagnostic step to make a specific diagnosis, such as the particular infectious agent, the type of lymphoma or Hodgkin lymphoma, or the specific type of metastatic malignancy. An international group of cytopathologists have begun the process of developing a system for the standardized reporting of lymph node FNAC. The group is addressing the pre-analytical issues related to the FNAC, including the role of clinical information and the use of ultrasound, and developing a structure of reporting categories based on the cytopathological findings linked to management recommendations. The basis of the system is the integration of the FNAC with the clinical setting, imaging, and ancillary tests that utilize the FNAC material, to produce a final report that will enhance patient care.

1.
Frable
WJ
.
Chapter 4, lymph nodes
. In:
Thin needle aspiration biopsy
.
Philadelphia
:
W.B. Saunders
;
1983
.
2.
Linsk
JA
,
Franzen
S
.
Chapter 14, diseases of the lymph node and spleen
. In:
Linsk
J
,
Franzen
S
, editors.
Clinical aspiration cytology
. 2nd ed.
Philadelphia
:
J.B. Lippincott
;
1989
.
3.
Geisinger
KR
,
Rainer
RO
,
Field
AS
.
Chapter 1, lymph nodes
. In:
Geisinger
K
,
Silverman
J
, editors.
FNA Cytology of superficial organs and body sites
.
Philadelphia
:
Churchill Livingstone
;
1999
.
4.
Caraway
NP
,
Katz
RL
.
Lymph nodes
. In:
Koss’ diagnostic cytology and its histopathologic bases
.
Lippincott Williams & Wilkins
;
2006
. p.
1186
228
.
5.
Skoog
L
,
Tani
E
.
Chapter 13, lymph nodes
. In:
Gray
W
,
Kocjan
G
, editors.
Diagnostic cytopathology
. 3rd ed.
Edinburgh
:
Churchill Livingstone Elsevier
;
2010
.
6.
Miliauskas
J
.
Chapter 5, lymph nodes
. In:
Orell and Sterrett’s fine needle aspiration Cytology
. 5th ed.
Edinburgh
:
Churchill Livingstone Elsevier
;
2012
.
7.
DeMay
RM
.
Chapter 13, lymph nodes
. In:
The art and science of cytopathology
. 2nd ed.
Chicago
:
ASCP
;
2012
.
8.
Field
AS
,
Geddie
WR
.
Lymph node and spleen cytohistology
.
Cambridge
:
Cambridge University Press
;
2014
.
9.
Wieczorek
TJ
,
Wakely
PE
.
Chapter 12 lymph nodes
. In:
Cibas
ES
,
Ducataman
BS
, editors.
Cytology: diagnostic principles and clinical correlates
. 4th ed.
Elsevier
;
2014
.
10.
Zeppa
P
,
Cozzolino
I
.
Cytopathology of lymph nodes and extranodal lymphoproliferative processes, monographs in clinical Cytology
.
Basel
:
Karger
;
2018
.
11.
Katz
RL
.
Modern approach to lymphoma diagnosis by fine-needle aspiration: restoring respect to a valuable procedure
.
Cancer
.
2005
;
105
(
6
):
429
31
.
12.
Zeppa
P
.
Haematocytopathology: why?
Cytopathology
.
2012
;
23
(
2
):
73
5
.
13.
Swerdlow
SH
,
Campo
E
,
Harris
NL
,
Jaffe
ES
,
Pileri
SA
,
Sten
H
, et al.
, editors.
WHO classification of tumours of haematopoietic and lymphoid tissues
. Revised 4th ed.
Lyon
:
IARC
;
2017
.
14.
Bazemore
AW
,
Smucker
DR
.
Lymphadenopathy and malignancy
.
Am Fam Physician
.
2002
;
66
(
11
):
2103
10
.
15.
Medeiros
LJ
,
O’Malley
DP
,
Caraway
NP
,
Vega
F
,
Elenitoba-Johnson
KSJ
,
Lim
MS
.
AFIP Atlas of Tumor Pathology. Tumors of the Lymph Nodes and Spleen. Needle core biopsy and fine-neede aspiration for the diagnosis of lymphoproliferative disorders. Fourth series, fascicle 25
.
Washington, DC
:
American Registry of Pathology Press
;
2017
. p.
43
64
.
16.
Barroca
H
,
Bode-Lesniewska
B
,
Cozzolino
I
,
Zeppa
P
.
Management of cytologic material, preanalytic procedures and biobanking in lymph node cytopathology
.
Cytopathology
.
2019
;
30
(
1
):
17
30
.
17.
Schmitt
F
,
Barroca
H
.
Role of ancillary studies in fine-needle aspiration from selected tumors
.
Cancer Cytopathol
.
2012
;
120
(
3
):
145
60
.
18.
Bardales
RH
.
The interventional cytopathologist. A new clinician/pathologist hybrid
. In:
Bardales
RH
, editor.
The invasive cytopathologist
.
New York
:
Springer
;
2014
. Vol.
90
; p.
351
4
.
19.
Manzo
JL
,
Cuda
J
,
Pantanowitz
L
,
Xing
J
,
Yu
J
,
Beasley
HS
, et al.
Clinical trial cytology: use of on-site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies
.
Cancer Cytopathol
.
2018
;
126
(
7
):
481
9
.
20.
Mathiot
C
,
Decaudin
D
,
Klijanienko
J
,
Couturier
J
,
Salomon
A
,
Dumont
J
, et al.
FNAC combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions
.
Diagn Cytopathol
.
2006
;
34
:
472
8
.
21.
Schmitt
FC
.
Molecular cytopathology and flow cytometry: pre-analytical procedures matter
.
Cytopathology
.
2011
;
22
(
6
):
355
7
.
22.
Saieg
MA
,
Geddie
WR
,
Boerner
SL
,
Liu
N
,
Tsao
M
,
Zhang
T
, et al.
The use of FTA cards for preserving unfixed cytological material for high-throughput molecular analysis
.
Cancer Cytopathol
.
2012
:
120
(
3
):
206
14
.
23.
Monaco
SE
,
Khalbuss
WE
,
Pantanowitz
L
.
Benign non-infectious causes of lymphadenopathy: a review of cytomorphology and differential diagnosis
.
Diagn Cytopathol
.
2012
;
40
(
10
):
925
38
.
24.
Cui
XW
,
Jenssen
C
,
Saftoiu
A
,
Ignee
A
,
Dietrich
CF
.
New ultrasound techniques for lymph node evaluation
.
World J Gastroenterol
.
2013
;
19
(
30
):
4850
60
.
25.
Field
AS
.
Cytopathology in low medical infrastructure countries: why and how to integrate to capacitate health care. Global health and pathology
.
Clin Lab Med
.
2018
;
38
:
175
82
.
26.
Wakely
PE
 Jr
.
The diagnosis of non-Hodgkin lymphoma using fine-needle aspiration cytopathology: a work in progress
.
Cancer Cytopathol
.
2010
;
118
(
5
):
238
43
.
27.
Ali
S
,
Cibas
ES
, editors.
The Bethesda system for reporting thyroid cytopathology
. 2nd ed.
Springer
;
2018
.
28.
Elkins
CT
,
Wakely
PE
 Jr
.
Cytopathology of “double-hit” non-Hodgkin lymphoma
.
Cancer Cytopathol
.
2011
;
119
(
4
):
263
71
.
29.
Jin
M
,
Wakely
PE
.
EUS and EBUS guided FNA and ancillary techniques, particularly flow cytometry, in diagnosing deep-seated lymphomas
.
Acta Cytol
.
2016
;
60
:
326
35
.
30.
Zeppa
P
,
Marino
G
,
Troncone
G
,
Fulciniti
F
,
De Renzo
A
,
Picardi
M
, et al.
Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions
.
Cancer
.
2004
;
102
(
1
):
55
65
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.